S&P 500 7,459.94 â–ŧ 73.83 (-0.98%) DOW 52,169.10 â–ŧ 383.87 (-0.73%) NASDAQ 25,535.42 â–ŧ 346.53 (-1.34%) US Markets Closed â€ĸ 03:06 AM ET

CCM

Concord Medical Services Holdings Limited

Price Chart
Latest Quote

$4.37

-0.13 (-2.89%)
Current Price
Previous Close $4.50
Open $4.60
Day High $4.60
Day Low $4.24
Volume 68,210
Fetched: 2026-07-16T15:18:42
Stock Information
Note: Financial values converted from CNY to USD
Shares Outstanding 2.82M
Total Debt $536.39M
Cash Equivalents $43.94M
Revenue $67.95M
Net Income $-13.70M
Sector Healthcare
Industry Medical Care Facilities
Market Cap $18.54M
EPS (TTM) $-3.13
Exchange NYQ
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$7.31B
Sales$67.95M
Income$-13.70M
Book/sh$-71.51
Cash/sh$105.77
Employees610
Financial Ratios
Quick Ratio0.17
Current Ratio0.48
Debt/Eq196.47
Returns & Margins
ROA-2.25%
ROE-21.88%
Gross Margin5.61%
Operating Margin-36.43%
Profit Margin-20.15%
Ownership
Insider Ownership25.65%
Institutional Ownership0.44%
Insider & Institutional transactions data not available
Valuation Ratios
Forward P/E-28.47
PEG0.56
P/S0.04
P/B-0.06
Analyst Data
Recommendationnone
Technical Indicators
SMA20$4.68
SMA50$4.84
SMA200$4.46
RSI40.87
ATR0.4029
Shares Float1.38M
Short Float0.53%
Short Ratio0.16
Volatility-0.96
Rel Volume0.12
Performance History
Week-15.45%
Month-9.15%
Quarter+9.21%
6 Months+3.14%
YTD+0.00%
Year-29.42%
3 Years-69.50%
5 Years-84.75%
10 Years-90.21%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-07-17 $4.27 7,400
2026-07-16 $4.35 154,100
2026-07-15 $4.50 2,500
2026-07-14 $4.37 20,900
2026-07-13 $4.68 183,600
2026-07-10 $5.05 32,100
2026-07-09 $4.88 43,400
2026-07-08 $4.69 138,700
2026-07-07 $4.80 156,400
2026-07-06 $4.68 45,700
2026-07-02 $4.39 19,600
2026-07-01 $4.51 127,600
2026-06-30 $4.72 17,600
2026-06-29 $4.73 48,600
2026-06-26 $4.69 51,300
2026-06-25 $4.41 6,800
2026-06-24 $4.72 41,900
2026-06-23 $4.56 140,000
2026-06-22 $5.35 3,300
2026-06-18 $5.32 24,600
About Concord Medical Services Holdings Limited

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, and helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, China.

Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Reconciled Cost Of Revenue $64,246,826 $68,447,831 $90,749,339 $92,298,852
Cost Of Revenue $64,246,826 $68,447,831 $90,749,339 $92,298,852
Total Revenue $68,062,817 $56,747,860 $79,426,844 $69,773,134
Operating Revenue $68,062,817 $56,747,860 $79,426,844 $69,773,134
Expenses
Interest Expense $22,513,451 $28,554,391 $24,485,517 $17,788,502
Total Expenses $103,435,565 $135,399,948 $147,855,018 $147,374,084
Other Income Expense $1,273,722 $6,177,505 $9,197,163 $-30,226,428
Other Non Operating Income Expenses $-1,138,191 $-1,369,199 $-1,592,817 $-32,014,486
Net Non Operating Interest Income Expense $-21,082,177 $-26,487,882 $-22,884,571 $-16,307,420
Interest Expense Non Operating $22,513,451 $28,554,391 $24,485,517 $17,788,502
Operating Expense $39,188,740 $66,952,117 $57,105,678 $55,075,232
Selling And Marketing Expense $7,712,681 $7,186,817 $8,320,869 $9,086,462
General And Administrative Expense $31,476,058 $59,765,300 $48,784,809 $45,988,770
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-13,717,263 $-45,557,643 $-43,993,204 $-72,370,828
Net Interest Income $-21,082,177 $-26,487,882 $-22,884,571 $-16,307,420
Interest Income $1,431,274 $2,066,509 $1,600,946 $1,481,082
Normalized Income $-14,079,959 $-51,079,668 $-51,369,286 $-71,619,936
Net Income From Continuing And Discontinued Operation $-13,717,263 $-45,557,643 $-43,993,204 $-72,370,828
Total Operating Income As Reported $-38,647,948 $-78,652,088 $-68,428,174 $-77,600,950
Net Income Common Stockholders $-13,717,263 $-45,557,643 $-43,993,204 $-72,370,828
Net Income $-13,717,263 $-45,557,643 $-43,993,204 $-72,370,828
Net Income Including Noncontrolling Interests $-56,077,449 $-96,375,263 $-78,483,746 $-113,655,046
Net Income Continuous Operations $-56,077,449 $-96,375,263 $-78,483,746 $-113,655,046
Pretax Income $-55,181,203 $-98,962,464 $-82,115,582 $-124,134,798
Special Income Charges $2,262,932 $7,150,015 $5,447,828 $-9,096,365
Earnings From Equity Interest $1,928,318 $1,876,441 $3,072,569 $2,608,188
Interest Income Non Operating $1,431,274 $2,066,509 $1,600,946 $1,481,082
Operating Income $-35,372,748 $-78,652,088 $-68,428,174 $-77,600,950
Gross Profit $3,815,992 $-11,699,971 $-11,322,495 $-22,525,718
Per Share
Diluted EPS - $-10.42 $-10.07 $-16.58
Basic EPS - $-10.42 $-10.07 $-16.58
Other
Tax Effect Of Unusual Items $120,899 $148,239 $341,328 $-69,237
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-11,091,635 $-56,752,737 $-46,362,255 $-85,896,546
Total Unusual Items $483,594 $5,670,263 $7,717,411 $-820,130
Total Unusual Items Excluding Goodwill $483,594 $5,670,263 $7,717,411 $-820,130
Reconciled Depreciation $22,059,711 $19,325,600 $18,985,221 $19,629,620
EBITDA (Bullshit earnings) $-10,608,041 $-51,082,474 $-38,644,844 $-86,716,676
EBIT $-32,667,752 $-70,408,073 $-57,630,065 $-106,346,296
Diluted NI Availto Com Stockholders $-13,717,263 $-45,557,643 $-43,993,204 $-72,370,828
Otherunder Preferred Stock Dividend $0 $0 $0 $0
Minority Interests $42,360,185 $50,817,620 $34,490,543 $41,284,217
Tax Provision $896,246 $-2,587,201 $-3,631,836 $-10,479,752
Gain On Sale Of Business $5,538,132 $7,150,015 $5,447,828 $-9,096,365
Impairment Of Capital Assets $3,275,200 $0 $0 $0
Gain On Sale Of Security $-1,779,338 $-1,479,752 $2,269,583 $8,276,235
Selling General And Administration $39,188,740 $66,952,117 $57,105,678 $55,075,232
Other Gand A $31,476,058 $59,765,300 $48,784,809 $45,988,770
Diluted Average Shares - $645,649 $645,649 $645,649
Basic Average Shares - $645,649 $645,649 $645,649
Gain On Sale Of Ppe - - $9,163 $-443
Fetched: 2026-07-16
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $-489,187,284 $-522,166,742 $-505,249,508 $-473,048,354
Total Assets $967,685,830 $994,145,483 $894,759,578 $887,516,154
Total Non Current Assets $828,473,142 $848,716,566 $803,537,581 $775,219,371
Other Non Current Assets $487,881 $470,736 $937,186 $1,159,031
Non Current Prepaid Assets $203,813 $396,394 $751,552 $1,071,682
Goodwill And Other Intangible Assets $178,352,211 $185,130,071 $191,630,663 $197,558,242
Other Intangible Assets $93,779,934 $100,557,794 $106,583,807 $112,511,386
Current Assets $139,212,688 $145,428,917 $91,221,997 $112,296,784
Other Current Assets $81,760,276 $78,001,777 $61,032,519 $56,954,038
Restricted Cash $136,122 $3,067,987 $4,770,914 $156,666
Inventory $6,793,527 $4,942,507 $5,963,199 $12,538,428
Receivables $6,510,346 $7,562,519 $10,862,549 $19,253,770
Accounts Receivable $6,510,346 $7,562,519 $10,862,549 $19,253,770
Allowance For Doubtful Accounts Receivable $-6,821,756 $-6,338,162 $-4,505,764 $-1,147,502
Gross Accounts Receivable $13,332,102 $13,900,681 $15,368,313 $20,401,272
Cash Cash Equivalents And Short Term Investments $44,012,417 $51,854,126 $8,592,817 $23,393,882
Cash And Cash Equivalents $44,012,269 $31,957,436 $8,592,817 $23,393,882
Investmentin Financial Assets - - $2,796,926 $7,404,080
Current Deferred Assets - - - $29,560
Prepaid Assets - - - $384,422
Receivables Adjustments Allowances - - - $-2,555,424
Other Receivables - - - $9,046,409
Taxes Receivable - - - $6,577,299
Loans Receivable - - - $43,471,773
Non Current Accounts Receivable - - - -
Accrued Interest Receivable - - - -
Debt
Net Debt $468,339,072 $521,750,691 $443,107,176 $420,592,247
Total Debt $537,244,041 $580,953,473 $487,097,423 $478,847,053
Long Term Debt And Capital Lease Obligation $386,048,497 $421,606,140 $326,192,892 $397,780,097
Long Term Debt $367,352,221 $401,077,910 $297,666,879 $368,227,479
Current Debt And Capital Lease Obligation $151,195,544 $159,347,333 $160,904,531 $81,066,956
Current Debt $144,999,120 $152,630,218 $154,033,114 $75,758,650
Other Current Borrowings $99,186,526 $73,708,103 $107,947,537 $52,776,680
Liabilities
Total Liabilities Net Minority Interest $694,242,719 $755,045,707 $636,558,708 $589,606,444
Total Non Current Liabilities Net Minority Interest $405,385,181 $440,922,872 $348,146,928 $423,890,207
Other Non Current Liabilities $610,996 $491,132 $669,968 $559,415
Non Current Deferred Liabilities $11,085,132 $12,248,005 $14,711,499 $16,638,635
Non Current Deferred Taxes Liabilities $11,085,132 $12,248,005 $14,711,499 $16,638,635
Current Liabilities $288,857,537 $314,122,836 $288,411,779 $165,716,237
Current Deferred Liabilities $14,143,956 $6,821,017 $8,780,373 $14,898,316
Payables And Accrued Expenses $123,518,038 $147,954,486 $118,702,785 $68,969,114
Payables $55,351,909 $67,016,557 $61,499,116 $57,882,799
Other Payable $32,127,847 $32,472,511 $39,864,915 $31,940,291
Total Tax Payable $5,593,556 $5,074,047 $2,533,402 $4,253,473
Income Tax Payable $1,118,682 $239,876 $224,948 $120,899
Accounts Payable $17,630,506 $29,469,999 $19,100,799 $21,689,034
Other Current Liabilities - - $24,091 $781,850
Derivative Product Liabilities - - - $0
Equity
Common Stock Equity $-310,835,073 $-337,036,671 $-313,618,845 $-275,490,111
Total Equity Gross Minority Interest $273,443,112 $239,099,776 $258,200,870 $297,909,710
Stockholders Equity $-310,835,073 $-337,036,671 $-313,618,845 $-275,490,111
Gains Losses Not Affecting Retained Earnings $-11,168,342 $-11,432,014 $-9,668,786 $-4,103,754
Other Equity Adjustments $-11,168,342 $-11,432,014 $-9,668,786 $-4,103,754
Retained Earnings $-660,012,300 $-646,295,037 $-600,737,393 $-556,744,190
Long Term Equity Investment $62,370,976 $69,785,105 $58,337,425 $57,312,743
Preferred Securities Outside Stock Equity - - - -
Other
Treasury Shares Number $1,788,627 $1,788,627 $1,788,627 $1,788,627
Ordinary Shares Number $19,250,915 $19,250,915 $19,250,915 $19,250,915
Share Issued $21,039,542 $21,039,542 $21,039,542 $21,039,542
Tangible Book Value $-489,187,284 $-522,166,742 $-505,249,508 $-473,048,354
Invested Capital $201,516,268 $216,671,456 $138,081,148 $168,496,018
Working Capital $-149,644,849 $-168,693,919 $-197,189,782 $-53,419,453
Capital Lease Obligations $24,892,700 $27,245,346 $35,397,430 $34,860,924
Total Capitalization $56,517,147 $64,041,239 $-15,951,967 $92,737,368
Minority Interest $584,278,185 $576,136,446 $571,819,715 $573,399,822
Treasury Stock $1,035 $1,035 $1,035 $1,035
Additional Paid In Capital $360,331,085 $320,675,895 $296,772,850 $285,343,349
Capital Stock $15,519 $15,519 $15,519 $15,519
Common Stock $15,519 $15,519 $15,519 $15,519
Non Current Accrued Expenses $7,640,556 $6,577,594 $6,572,569 $8,912,061
Long Term Capital Lease Obligation $18,696,276 $20,528,230 $28,526,014 $29,552,618
Current Deferred Revenue $14,143,956 $6,821,017 $8,780,373 $14,898,316
Current Capital Lease Obligation $6,196,424 $6,717,115 $6,871,416 $5,308,307
Line Of Credit $45,812,595 $78,922,115 $46,085,577 $22,981,970
Current Accrued Expenses $68,166,128 $80,937,929 $57,203,668 $11,086,314
Investments And Advances $62,370,976 $69,785,105 $58,337,425 $64,716,823
Goodwill $84,572,277 $84,572,277 $85,046,856 $85,046,856
Net PPE $587,058,262 $592,934,260 $551,880,755 $510,713,593
Accumulated Depreciation $-73,672,632 $-59,423,296 $-58,240,027 $-47,939,405
Gross PPE $660,730,893 $652,357,556 $610,120,781 $558,652,999
Leases $11,512,563 $11,481,378 $12,084,837 $11,089,566
Construction In Progress $372,726,149 $366,866,557 $365,203,388 $316,423,752
Other Properties $147,150,613 $147,502,372 $104,181,353 $106,351,764
Machinery Furniture Equipment $7,668,046 $8,550,252 $9,269,436 $9,127,254
Buildings And Improvements $121,673,521 $117,956,997 $119,381,768 $115,660,662
Properties $0 $0 $0 $0
Inventories Adjustments Allowances $-79,811 $-87,349 $-84,984 $-89,713
Finished Goods $1,083,062 $404,966 $596,512 $1,462,607
Raw Materials $5,790,275 $4,624,889 $5,451,670 $11,165,534
Other Short Term Investments $148 $19,896,690 $0 -
Available For Sale Securities - - $2,796,926 $7,404,080
Fetched: 2026-07-16
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $-43,328,113 $-119,506,805 $-58,584,691 $-88,900,389
Operating Activities
Operating Cash Flow $-29,829,147 $-58,786,435 $-40,861,811 $-32,026,901
Cash Flow From Continuing Operating Activities $-29,829,147 $-58,786,435 $-40,861,811 $-32,026,901
Operating Gains Losses $-7,156,518 $-7,113,361 $-9,299,143 $6,338,605
Investing Activities
Capital Expenditure $-13,498,966 $-60,720,370 $-17,722,880 $-56,873,488
Investing Cash Flow $7,975,909 $-87,709,729 $-7,047,148 $-17,557,199
Cash Flow From Continuing Investing Activities $7,975,909 $-87,709,729 $-7,047,148 $-17,557,199
Net Other Investing Changes - - - $36,303,431
Financing Activities
Financing Cash Flow $29,150,460 $169,380,883 $38,080,552 $56,619,571
Cash Flow From Continuing Financing Activities $29,150,460 $169,380,883 $38,080,552 $56,619,571
Net Other Financing Charges $14,303,873 $25,888,710 $35,209,431 $-12,254,656
Dividends Received Cfi $471,179 $1,477,978 $1,776,825 $753,917
Issuance Of Capital Stock - $75,454,039 $0 $0
Net Common Stock Issuance - $75,454,039 $0 $0
Common Stock Issuance - $75,454,039 $0 $0
Other
Repayment Of Debt $-128,672,634 $-258,874,976 $-66,570,946 $-58,321,168
Issuance Of Debt $143,519,221 $402,367,150 $69,442,067 $127,195,395
Interest Paid Supplemental Data $27,044,932 $27,830,921 $22,518,328 $21,468,668
Income Tax Paid Supplemental Data $16,110 $21,874 $132,722 $445,315
End Cash Position $44,148,391 $35,025,423 $13,363,731 $23,550,548
Beginning Cash Position $35,025,423 $13,363,731 $23,550,548 $23,486,699
Effect Of Exchange Rate Changes $1,825,746 $-1,223,027 $-358,410 $-6,971,623
Changes In Cash $7,297,222 $22,884,719 $-9,828,407 $7,035,472
Net Issuance Payments Of Debt $14,846,587 $143,492,174 $2,871,120 $68,874,228
Net Short Term Debt Issuance $-11,503,843 $43,507,244 $-15,542,862 $2,937,038
Short Term Debt Payments $-64,596,663 $-53,255,841 $-65,453,447 $-29,204,554
Short Term Debt Issuance $53,092,820 $96,763,085 $49,910,585 $32,141,592
Net Long Term Debt Issuance $26,350,430 $99,984,930 $18,413,983 $65,937,189
Long Term Debt Payments $-64,075,971 $-205,619,135 $-1,117,499 $-29,116,614
Long Term Debt Issuance $90,426,401 $305,604,065 $19,531,482 $95,053,803
Net Investment Purchase And Sale $19,896,543 $-14,730,565 $0 $1,766,036
Sale Of Investment $19,896,543 $15,509,903 $0 $1,766,036
Net Business Purchase And Sale $-1,478 $-13,736,773 $8,853,089 $-339,935
Sale Of Business $0 $1,338,605 $8,867,869 $0
Purchase Of Business $-1,478 $-15,075,378 $-14,780 $-339,935
Net Intangibles Purchase And Sale $-4,434 $-1,501,626 $-622,377 $-152,675
Purchase Of Intangibles $-4,434 $-1,501,626 $-622,377 $-152,675
Net PPE Purchase And Sale $-12,385,901 $-59,218,744 $-17,054,686 $-55,887,972
Sale Of PPE $1,108,631 $0 $45,817 $832,841
Purchase Of PPE $-13,494,532 $-59,218,744 $-17,100,503 $-56,720,813
Change In Working Capital $-14,460,391 $-22,071,092 $-8,130,506 $15,523,648
Change In Other Working Capital $5,843,039 $-456,547 $-6,086,166 $8,449,306
Change In Other Current Liabilities $-2,352,646 $-2,856,932 $-2,682,087 $-433,787
Change In Other Current Assets $-141,590 $-67,691 $239,137 $-2,217
Change In Payables And Accrued Expense $-40,695,539 $28,182,827 $10,566,362 $33,561,486
Change In Accrued Expense $-23,500,445 $14,415,017 $8,130,062 $16,629,620
Change In Payable $-17,195,094 $13,767,810 $2,436,299 $16,931,866
Change In Account Payable $-18,073,900 $13,752,883 $2,332,102 $16,810,967
Change In Tax Payable $878,806 $14,928 $104,197 $120,899
Change In Income Tax Payable $878,806 $14,928 $104,197 $120,899
Change In Prepaid Assets $23,836,832 $-49,609,373 $-22,130,950 $-19,236,773
Change In Inventory $-1,858,705 $960,390 $6,575,377 $-6,909,548
Change In Receivables $908,218 $1,776,234 $5,387,822 $95,182
Changes In Account Receivables $908,218 $1,776,234 $5,387,822 $95,182
Other Non Cash Items $24,702,336 $31,891,370 $28,429,206 $50,831,956
Stock Based Compensation $0 $0 $0 $-874,815
Unrealized Gain Loss On Investment Securities $0 $-1,077,446 $0 $0
Provisionand Write Offof Assets $-1,009,164 $18,947,089 $9,564,293 $798,108
Asset Impairment Charge $3,275,200 $0 $0 $0
Deferred Tax $-1,162,873 $-2,313,331 $-1,927,136 $-10,618,978
Deferred Income Tax $-1,162,873 $-2,313,331 $-1,927,136 $-10,618,978
Depreciation Amortization Depletion $22,059,711 $19,325,600 $18,985,221 $19,629,620
Depreciation And Amortization $22,059,711 $19,325,600 $18,985,221 $19,629,620
Amortization Cash Flow $6,761,455 $6,796,039 $6,847,473 $6,521,135
Amortization Of Intangibles $6,761,455 $6,796,039 $6,847,473 $6,521,135
Depreciation $15,298,257 $12,529,560 $12,137,748 $13,108,484
Earnings Losses From Equity Investments $-7,466,450 $-1,858,705 $-8,614,692 $-2,608,188
Gain Loss On Sale Of PPE $309,932 $1,937,629 $-9,163 $443
Gain Loss On Sale Of Business $0 $-7,167,751 $94,295 $9,096,365
Net Income From Continuing Operations $-56,077,449 $-96,375,263 $-78,483,746 $-113,655,046
Purchase Of Investment - $-30,240,469 $0 $0
Gain Loss On Investment Securities - $-24,534 $-769,583 $-150,015
Fetched: 2026-07-16